Autoantibodies to Estrogen Receptor α in Systemic Sclerosis (SSc) as Pathogenetic Determinants and Markers of Progression

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Giovannetti, Antonello ^a   Maselli, Angela ^b   Colasanti, Tania ^b,c   Rosato, Edoardo ^a   Salsano, Felice ^a   Pisarri, Simonetta ^a   Mezzaroma, Ivano ^a   Malorni, Walter ^b,d   Ortona, Elena ^b,d   Pierdominici, Marina ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d San Raffaele Pisana   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; CD45RA ANTIGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CD4 LYMPHOCYTE PERCENTAGE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HOMEOSTASIS; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PATHOGENESIS; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEMOGRAPHY; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 84884217070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074332     Document Type: Article

References (31)

1. Ascenzi P, Bocedi A, Marino M, (2006) Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 27: 299-402.
2. Rider V, Abdou NI, (2001) Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 1: 1009-1024.
3. Straub RH, (2007) The complex role of estrogens in inflammation. Endocr Rev 28: 521-574.
4. Cutolo M, Brizzolara R, Atzeni F, Capellino S, Straub RH, et al. (2010) The immunomodulatory effects of estrogens: clinical relevance in immune-mediated rheumatic diseases. Ann N Y Acad Sci 1193: 36-42.
5. Karpuzoglu E, Zouali M, (2011) The Multi-faceted Influences of Estrogen on Lymphocytes: Toward Novel Immuno-interventions Strategies for Autoimmunity Management. Clin Rev Allergy Immunol 40: 16-26.
6. Levin ER, (2009) Plasma membrane estrogen receptors. Trends Endocrinol Metab 20: 477-482.
7. Mendelsohn ME, Karas RH, (2010) Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest 120: 2277-2279.
8. Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Delunardo F, et al. (2010) Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 132: 79-85.
9. Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, et al. (2012) Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum 64: 778-787.
10. Gabrielli A, Avvedimento EV, Krieg T, (2009) Scleroderma. N Engl J Med 360: 1989-2003.
11. Kalogerou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E, et al. (2005) Early T cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis 64: 1233-1235.
12. Gu YS, Kong J, Cheema GS, Keen CL, Wick G, et al. (2008) The immunobiology of systemic sclerosis. Semin Arthritis Rheum 38: 132-160.
13. Soldano S, Montagna P, Brizzolara R, Sulli A, Parodi A, et al. (2010) Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. Ann N Y Acad Sci 1193: 25-29.
14. Soldano S, Montagna P, Villaggio B, Parodi A, Gianotti G, et al. (2009) Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts. Ann Rheum Dis 68: 599-602.
15. Shi-Wen X, Panesar M, Vancheeswaran R, Mason J, Haskard D, et al. (1994) Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen. Arthritis Rheum 37: 1689-1697.
16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590.
17. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, et al. (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60: 592-598.
18. Cutolo M, Sulli A, Pizzorni C, Accardo S, (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27: 155-160.
19. American Thoracic Society (1995) Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique-1995 update. Am J Respir Crit Care Med 152: 2185-2198.
20. Giovannetti A, Pierdominici M, Mazzetta F, Marziali M, Renzi C, et al. (2007) Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 178: 3932-3943.
21. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
22. Sakkas LI, Platsoucas CD, (2004) Is systemic sclerosis an antigen-driven T cell disease? Arthritis Rheum 50: 1721-1733.
23. Mathian A, Parizot C, Dorgham K, Trad S, Arnaud L, et al. (2012) Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Ann Rheum Dis 71: 1227-1234.
24. Giovannetti A, Rosato E, Renzi C, Maselli A, Gambardella L, et al. (2010) Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes. Clin Immunol 137: 122-133.
25. Campbell DJ, Koch MA, (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11: 119-130.
26. Liu X, Gao N, Li M, Xu D, Hou Y, et al. (2013) Elevated Levels of CD4(+)CD25(+)FoxP3(+) T Cells in Systemic Sclerosis Patients Contribute to the Secretion of IL-17 and Immunosuppression Dysfunction. PLoS One 8: e64531.
27. Kim JR, Chae JN, Kim SH, Ha JS, (2012) Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease. J Korean Med Sci 27: 1009-13.
28. Racanelli V, Prete M, Musaraj G, Dammacco F, Perosa F, (2011) Autoantibodies to intracellular antigens: generation and pathogenetic role. Autoimmun Rev 10: 503-508.
29. Chen W, Frank ME, Jin W, Wahl SM, (2001) TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14: 715-725.
30. Rao PE, Petrone AL, Ponath PD, (2005) Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}. J Immunol 174: 1446-1455.
31. van Bon L, Cossu M, Radstake TR, (2011) An update on an immune system that goes awry in systemic sclerosis. Curr Opin Rheumatol 23: 505-510.